Mucinous, endometrioid, and serous ovarian cancers with peritoneal dissemination are potent candidates for P-cadherin targeted therapy: a retrospective cohort study.

Kayo KayahashiYasunari MizumotoAyumi MatsuokaTakeshi ObataJunpei IwadareMitsuhiro NakamuraTakiko DaikokuHiroshi Fujiwara

Published in: BMC cancer (2021)

Mucinous, endometrioid, and serous ovarian cancer patients accompanied with peritoneal disseminations are the most potent candidates for P-cadherin targeted drug delivery strategies. P-cadherin-targeted therapy may benefit and improve survival of poor-prognosis populations.

Keyphrases

poor prognosis
high grade
low grade
drug delivery
long non coding rna
cell adhesion
cell migration
endometrial cancer
cancer therapy
anti inflammatory
clear cell
free survival
drug release